Kiromic BioPharma, Inc. (KRBPQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 28, 2026
Kiromic BioPharma Market Cap
Kiromic BioPharma has a market cap or net worth of $157 as of February 2, 2026. Its market cap has decreased by -100.00% in one year.
Market Cap
157.00
Enterprise Value
13.43M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 16, 2020, Kiromic BioPharma's market cap has decreased from 84.33M to 157.00, a decrease of -100.00%. That is a compound annual growth rate of -91.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 157.00 | 7,750.00% |
| Dec 30, 2025 | 2.00 | -100.00% |
| Dec 31, 2024 | 1.38M | 26.04% |
| Dec 29, 2023 | 1.09M | -66.79% |
| Dec 30, 2022 | 3.30M | -86.04% |
| Dec 31, 2021 | 23.62M | -61.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobac Pharmaceuticals | 250.00 |
| NanoLogix | 163.00 |
| Poniard Pharmaceuticals | 150.00 |
| Q BioMed | 145.00 |
| NexImmune | 139.00 |
| Seelos Therapeutics | 136.00 |
| PsyBio Therapeutics | 133.00 |
| Marizyme | 132.00 |